Felicia Gray

Computer Science · University of Michigan

Established · publishing since 2000Rising activity

Computational Drug Discovery Methods Protein Structure and Dynamics Epigenetics and DNA Methylation Protein Degradation and Inhibitors Microtubule and mitosis dynamics

Publications

Citations

317

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 2000

In context

Among 615 established Computer Science PIs within our index

Citations: 317cohort median 1,709

Publications / year (recent): 2.8cohort median 4.2

Typically publishes in teams of ~16 · 8% small-team papers (≤3 authors) · across 7 venues

Publication cadence

Publications per year over the last 10 years — averaging 2.8/year recently

Recent publications

Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations
ACS Medicinal Chemistry Letters · 2025
Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study
Nature Communications · 2025
Abstract 3025: Optimization of therapeutic index of SGR-3515, a first-in-class Wee1/Myt1 inhibitor through intermittent dosing for monotherapy and combination with chemotherapy in xenograft tumor models
Cancer Research · 2025
Abstract 4376: Preclinical characterization of SGR-4174, a potent and selective SOS1 inhibitor for the treatment of pan KRAS mutant cancers in combination with KRAS pathway inhibitors
Cancer Research · 2025
Abstract 358: INK4A/B as predictive biomarkers for enhanced efficacy of dual WEE1 and PKMYT1 inhibition in CDK4/6 inhibitor-resistant breast cancer
Cancer Research · 2025
<i>In Silico</i> Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
Journal of Medicinal Chemistry · 2024
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
ChemRxiv · 2024
Harnessing free energy calculations to achieve kinome-wide selectivity in drug discovery campaigns: Wee1 case study
ChemRxiv · 2024
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
ChemRxiv · 2024
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
ChemRxiv · 2024
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
ChemRxiv · 2024
147 (PB135): Discovery of SGR-3515, a first-in-class Wee1/Myt1 inhibitor with differentiated pharmacological properties in xenograft tumor models
European Journal of Cancer · 2024
ULD complex
Open MIND · 2016

Publishes in

Cancer Research×5
ChemRxiv×5
Nature Communications×2
Journal of Medicinal Chemistry×2
Nature Chemical Biology×1

Similar researchers

By research-topic overlap

Woong‐Hee Shin
Computer Science · Purdue University West Lafayette
Jianwen Chen
Computer Science · The Ohio State University
Shuhan Liu
Computer Science · University of Michigan
Anton V. Sinitskiy
Computer Science · Purdue University West Lafayette
Xiang Liu
Computer Science · Purdue University West Lafayette

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 25, 2026.

Claim or correct this profile